Ribonucleotide Reductase Subunit M2 Can Be New Molecular Target and Prognostic Biomarker of Hepatocellular Carcinoma
Keyword(s):
Keyword(s):
2015 ◽
Vol 211
(3)
◽
pp. 198-202
◽
2017 ◽